OAC
OMERS Administration Corp’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $224M | Buy |
287,936
+128,369
| +80% | +$100M | 1.76% | 12 |
|
2025
Q1 | $132M | Buy |
159,567
+120,895
| +313% | +$99.8M | 1.15% | 29 |
|
2024
Q4 | $29.9M | Buy |
38,672
+2,015
| +5% | +$1.56M | 0.26% | 50 |
|
2024
Q3 | $32.5M | Buy |
36,657
+100
| +0.3% | +$88.6K | 0.3% | 52 |
|
2024
Q2 | $33.1M | Buy |
+36,557
| New | +$33.1M | 0.32% | 48 |
|
2019
Q2 | – | Sell |
-10,970
| Closed | -$1.48M | – | 440 |
|
2019
Q1 | $1.48M | Buy |
+10,970
| New | +$1.48M | 0.02% | 177 |
|
2018
Q4 | – | Sell |
-89,700
| Closed | -$9.63M | – | 270 |
|
2018
Q3 | $9.63M | Sell |
89,700
-6,200
| -6% | -$665K | 0.09% | 68 |
|
2018
Q2 | $8.18M | Buy |
95,900
+14,500
| +18% | +$1.24M | 0.08% | 85 |
|
2018
Q1 | $6.3M | Buy |
81,400
+19,900
| +32% | +$1.54M | 0.06% | 132 |
|
2017
Q4 | $5.19M | Buy |
+61,500
| New | +$5.19M | 0.05% | 166 |
|
2016
Q3 | – | Sell |
-17,900
| Closed | -$1.41M | – | 628 |
|
2016
Q2 | $1.41M | Sell |
17,900
-22,100
| -55% | -$1.74M | 0.03% | 289 |
|
2016
Q1 | $2.88M | Buy |
40,000
+21,700
| +119% | +$1.56M | 0.06% | 177 |
|
2015
Q4 | $1.54M | Buy |
+18,300
| New | +$1.54M | 0.04% | 231 |
|
2015
Q1 | – | Sell |
-632,250
| Closed | -$43.6M | – | 447 |
|
2014
Q4 | $43.6M | Sell |
632,250
-271,200
| -30% | -$18.7M | 1.32% | 20 |
|
2014
Q3 | $58.6M | Buy |
903,450
+750
| +0.1% | +$48.6K | 1.75% | 11 |
|
2014
Q2 | $56.1M | Sell |
902,700
-182,800
| -17% | -$11.4M | 1.82% | 13 |
|
2014
Q1 | $63.9M | Buy |
+1,085,500
| New | +$63.9M | 2.07% | 12 |
|
2013
Q4 | – | Sell |
-5,100
| Closed | -$257K | – | 305 |
|
2013
Q3 | $257K | Hold |
5,100
| – | – | 0.02% | 137 |
|
2013
Q2 | $251K | Buy |
+5,100
| New | +$251K | 0.02% | 133 |
|